We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Gracell

News List

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco prnasia
January 05, 2020
Focused exclusively on companies defining the healthcare industry, the J.P. Morgan Healthcare Conference is the largest of its kind and will welcome over 400 public and private companies to deliver presentations to over 8,000 attendees, including investor
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies En-CPhI.CN
December 10, 2019
Gracell Biotechnologies Co., Ltd, a clinical-stage immune cell therapy company, announced the progressive clinical outcomes for leading product candidates FasTCAR-19 ...
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia En-CPhI.cn
June 24, 2019
Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed

Previous page 1 2 Next page